Brief: Diasorin Q3 Net Profit EUR 38 Mln
05/11/2025 16:55
Nov 5 (Reuters) - DiaSorin SpA DIAS.MI: SEES FY 2025 ADJUSTED EBITDA MARGIN APPROX. 33% SEES FY 2025 EX-COVID REVENUES APPROX. +5%, APPROX. +4% INCLUDING COVID REVENUES Q3 NET PROFIT EUR 38 MLN Q3 ADJ EBITDA EUR 88 MLN Q3 REVENUE EUR 280 MLN Further company coverage: DIAS.MI (Reporting by Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48587696600;))
Recent news on Diasorin
See all newsEquita upgrades Diasorin, sees 'solid' Q3
Brief: Diasorin Obtained FDA Approval For Fully Automated Laboratory Serology Tests For Human Parvovirus B19 Igm And Human Parvovirus B19 Igg On The Liaison Xl
Europe Research Roundup: Allianz, Mercedes-Benz, Tesco
European life sciences stocks rise on strong sector momentum
Italy - Factors to watch on September 21